Category OAFI News

27 Jul

OAFI hosts the I International Congress for OA Patients

Osteoarthritis Foundation International (OAFI) together with other patients’ associations that treat rheumatologic diseases recognized worldwide are meeting next 9th and 10th of October to find solutions to osteoarthritis It is estimated that 242 million people have osteoarthritis in the world and the number of patients is increasing Osteoarthritis (OA) is a degenerative joint disease that affects both the […]

24 Jul

Osteoarthritis, a serious disease

Dr. Josep Vergés, President and CEO of the Osteoarthritis Foundation International (OAFI) It is considered a disease associated with old age and with very little glamour, if any disease has glamour at all. However, osteoarthritis is a very complex pathology that affects both older people and other at-risk groups. Especially post-menopausal women, sportsmen and women […]

20 Jul

My Summer With Osteoarthritis

Don’t let osteoarthritis stop you from having fun and enjoying yourself this summer! Send us a photo of your Summer: Mail: info@oafifoundation.com Whatsapp: (+34) 602 252 279. Or posting it in the social networks using #MySummerWithOA Osteoarthritis is a serious disease that causes pain and directly affects the mobility and autonomy of those who suffer […]

27 Jun

OAFI supporting #BCN4EMA

Osteoarthritis Foundation International (OAFI) supports Barcelona’s candidacy to host the European Medicines Agency The International Osteoarthritis Foundation (OAFI), supports Barcelona’s candidacy as the future home of the European Medicines Agency. OAFI has joined the more than 200 economic biomedical, social and cultural organisations that have signed the manifesto to express their support for Barcelona to […]

28 Apr

Patient empowerment in clinical trials

Josep Vergés highlights the need for patient empowerment in the Master’s Degree in Monitoring and Management of Clinical Trials at the Universidad Autónoma of Madrid. An empowered patient is better informed, more autonomous and can better manage his/her pathology. Dr. Josep Vergés, President of the OAFI Foundation, has participated as a lecturer in the Master’s […]

3 Apr

OAFI visits INFARMA, the European meeting point of the Pharmaceutical Industry

Last March, the Osteoarthritis Foundation International (OAFI) was invited by the Pharmacists Association of Barcelona to Infarma, the European meeting point of the Pharmaceutical Industry. During the event, Dr. Josep Vergés, President of OAFI, gave a lecture on joint health and took the opportunity to present OAFI Foundation to the attendants. https://www.youtube.com/watch?v=TouEqVYfVr4

30 Mar

AECOSAR and OAFI join forces in the fight against osteoarthritis

Both entities will collaborate at scientific and institutional level to improve joint health in society The Spanish Association for Osteoporosis and Osteoarthritis (Asociación Española con la Osteoporosis y la Artrosis “AECOSAR”) and the Osteoarthritis Foundation International (OAFI) have signed an agreement to work together for the benefit and rights of osteoarthritis patients in Spain. Mª […]

29 Mar

The Spanish Rheumatology Society and OAFI sign an agreement to collaborate in helping improve the life of osteoarthritis patients

With this collaboration, the Spanish Rheumatology Society joins the Osteoarthritis World Association, led by OAFI and formed by entities involved in the advancement of the knowledge and research on the disease Both entities will begin their collaboration working on a study linked to the sexual health of patients with osteoarthritis The Spanish Rheumatology Society (in […]

29 Mar

SEMERGEN and OAFI sign a collaborative agreement to promote osteoarthritis research in Primary Healthcare

Both entities have established an agreement to collaborate jointly in the prevention and treatment of osteoarthritis disease SEMERGEN’s Research Agency will join the Global Osteoarthritis Cluster, a worldwide cluster led by OAFI and made up of patients, medical societies, scientific societies, public health administrations, partners and technology companies, among other agents. The Research Agency of […]

14 Mar

SETRADE and OAFI JOIN FORCES TO prevent osteoarthritis in SPORTSMEN AND WOMEN

Both institutions promote clinical research projects of new pharmacological treatments to improve the joint health of athletes Osteoarthritis is the most common chronic pathology among athletes and top-level sportsment and women. The Spanish Society of Sports Traumatology (SETRADE) and Osteoarthritis Foundation International (OAFI) have signed an agreement to work together on clinical research projects linked […]

OAFI is the International Osteoarthritis Foundation, the first and only foundation aimed exclusively at people with osteoarthritis worldwide.

CONTACT

The Foundation

Actions